首页> 外文期刊>Statistical methods in medical research >Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints
【24h】

Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints

机译:贝叶斯群体借用设计与分析二进制端点的篮子试验分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Master protocol designs are often proposed to improve the efficiency of drug development with multiple subgroups. In the basket trial design, different subgroups can have similar biological pathogenesis pathways. Hence, a target therapy can result in similar responses. A good information sharing strategy between different subgroups can potentially improve the efficiency of evaluating treatment efficacy. In traditional hierarchical models, based on the exchangeability assumption, all subgroups are placed into the same sharing pool for cross subgroup information sharing. However, due to the heterogeneity between subgroups, there can be large differences in drug efficacy. Under such cases, strong borrowing across all subgroups is not suitable and no borrowing can be inefficient, because the treatment effect is analyzed in each subgroup separately. We propose a Bayesian cluster hierarchical model (BCHM) to improve the operating characteristics of estimating the treatment effect in multiple subgroups in basket trials. Bayesian nonparametric method is applied to dynamically calculate the number of clusters by conducting a multiple cluster classification based on subgroup outcomes. A hierarchical model is used to compute the posterior probability of the treatment effect, with the borrowing strength determined by the Bayesian nonparametric clustering and the similarities between subgroups. We apply the BCHM to clinical trials with binary endpoints. For treatment effect estimation, the BCHM yields lower mean squared error values, when compared to the independent analyses. In scenarios with a heterogeneous treatment effect, the BCHM provides lower mean squared error values compared to traditional hierarchical models. In addition, we can construct a loss function to optimize the design parameters. BCHM provides a balanced approach and smart borrowing, which yields better results in assessing the treatment effect in different scenarios compared to other conventional methods.
机译:常规协议设计通常提出提高多个亚组的药物发育效率。在篮子试验设计中,不同的亚组可以具有类似的生物发病机理途径。因此,靶疗法可能导致类似的反应。不同亚组之间的良好信息共享策略可能会提高评估治疗效果的效率。在传统的分层模型中,基于交换性假设,所有子组都被放置到相同的共享池中,用于交叉子组信息共享。然而,由于亚组之间的异质性,药物功效可能存在很大的差异。在这种情况下,所有亚组的强烈借贷不合适,并且没有借款可以效率低下,因为分别在每个亚组中分析治疗效果。我们提出了一种贝叶斯簇层次模型(BCHM),以改善篮子试验中多个亚组中治疗效果的操作特征。应用贝叶斯非参数方法以通过基于子组结果进行多个群集分类动态计算群集数。分层模型用于计算治疗效果的后验概率,贝叶斯非参数聚类和子组之间的相似性决定的借贷强度。我们将BCHM与二进制端点应用于临床试验。对于处理效果估计,与独立分析相比,BCHM产生较低的平均平方误差值。在具有异质处理效果的情况下,BCHM与传统的分层模型相比提供了较低的平均方形误差值。此外,我们可以构建损失功能以优化设计参数。 BCHM提供了一种平衡的方法和智能借用,与其他常规方法相比,在不同场景中评估治疗效果的效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号